Robert R. Tufts - Net Worth and Insider Trading
Robert R. Tufts Net Worth
The estimated net worth of Robert R. Tufts is at least $28 dollars as of 2024-04-24. Robert R. Tufts is the Director of NovaBay Pharmaceuticals Inc and owns about 366 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $28. Details can be seen in Robert R. Tufts's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert R. Tufts has not made any transactions after 2011-08-15 and currently still holds the listed stock(s).
Transaction Summary of Robert R. Tufts
Robert R. Tufts Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert R. Tufts owns 1 companies in total, including NovaBay Pharmaceuticals Inc () .
Click here to see the complete history of Robert R. Tufts’s form 4 insider trades.
Insider Ownership Summary of Robert R. Tufts
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NovaBay Pharmaceuticals Inc | 2011-08-15 | director |
Robert R. Tufts Latest Holdings Summary
Robert R. Tufts currently owns a total of 1 stock. Robert R. Tufts owns 366 shares of NovaBay Pharmaceuticals Inc (NBY) as of August 15, 2011, with a value of $28.
Latest Holdings of Robert R. Tufts
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2011-08-15 | 366 | 0.08 | 28 |
Holding Weightings of Robert R. Tufts
Robert R. Tufts Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert R. Tufts has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 6 shares on August 15, 2011, which cost Robert R. Tufts around $4,250.
Insider Trading History of Robert R. Tufts
- 1
Robert R. Tufts Trading Performance
GuruFocus tracks the stock performance after each of Robert R. Tufts's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert R. Tufts is 29.41%. GuruFocus also compares Robert R. Tufts's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert R. Tufts within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert R. Tufts's insider trading performs compared to the benchmark.
Performance of Robert R. Tufts
Average Return
36.35%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.24 | 29.41 | 65.88 | 36.35 | 28.29 | 6.61 |
| Relative Return to S&P 500(%) | 7.86 | 24.98 | 54.36 | 19.71 | 10.87 | -10.89 |
Robert R. Tufts Ownership Network
Ownership Network List of Robert R. Tufts
Ownership Network Relation of Robert R. Tufts
Robert R. Tufts Owned Company Details
What does NovaBay Pharmaceuticals Inc do?
Who are the key executives at NovaBay Pharmaceuticals Inc?
Robert R. Tufts is the director of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .
NovaBay Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Robert R. Tufts made no insider transaction in NovaBay Pharmaceuticals Inc (). Other recent insider transactions involving NovaBay Pharmaceuticals Inc () include a net sale of 11,921 shares made by Audrey Kunin , and a net sale of 11,921 shares made by Jeffrey Kunin .
In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 23,842 shares of NovaBay Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,842 shares.
NovaBay Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
NovaBay Pharmaceuticals Inc Insider Transactions
Robert R. Tufts Mailing Address
Above is the net worth, insider trading, and ownership report for Robert R. Tufts. You might contact Robert R. Tufts via mailing address: C/o Novabay Pharmaceuticals, Inc., 5980 Horton Street, Suite 550, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
